These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28619456

  • 1. How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation.
    Pinto JT, Radivojev S, Zellnitz S, Roblegg E, Paudel A.
    Int J Pharm; 2017 Aug 07; 528(1-2):416-428. PubMed ID: 28619456
    [Abstract] [Full Text] [Related]

  • 2. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A.
    Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921
    [Abstract] [Full Text] [Related]

  • 3. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 4. Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.
    Zellnitz S, Pinto JT, Brunsteiner M, Schroettner H, Khinast J, Paudel A.
    Pharm Res; 2019 Apr 09; 36(6):80. PubMed ID: 30968221
    [Abstract] [Full Text] [Related]

  • 5. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

  • 6. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 7. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 8. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W, Rades T, Rantanen J, Yang M.
    Int J Pharm; 2019 Jun 30; 565():1-8. PubMed ID: 30999050
    [Abstract] [Full Text] [Related]

  • 9. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM.
    Int J Nanomedicine; 2013 Jun 30; 8():275-93. PubMed ID: 23355776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Jun 30; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 12. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
    Müller T, Krehl R, Schiewe J, Weiler C, Steckel H.
    Eur J Pharm Biopharm; 2015 May 30; 92():130-8. PubMed ID: 25769680
    [Abstract] [Full Text] [Related]

  • 13. Impact of drug particle shape on permeability and cellular uptake in the lung.
    Zellnitz S, Zellnitz L, Müller MT, Meindl C, Schröttner H, Fröhlich E.
    Eur J Pharm Sci; 2019 Nov 01; 139():105065. PubMed ID: 31493448
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 01; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X, Hayes D, Zwischenberger JB, Kuhn RJ, Mansour HM.
    Drug Des Devel Ther; 2013 Mar 01; 7():59-72. PubMed ID: 23403805
    [Abstract] [Full Text] [Related]

  • 18. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
    Molina C, Kaialy W, Chen Q, Commandeur D, Nokhodchi A.
    Drug Deliv Transl Res; 2018 Dec 01; 8(6):1769-1780. PubMed ID: 29260462
    [Abstract] [Full Text] [Related]

  • 19. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy.
    Acosta MF, Muralidharan P, Grijalva CL, Abrahamson MD, Hayes D, Fineman JR, Black SM, Mansour HM.
    Ther Adv Respir Dis; 2021 Dec 01; 15():1753466621998245. PubMed ID: 33719747
    [No Abstract] [Full Text] [Related]

  • 20. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
    Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM.
    AAPS PharmSciTech; 2014 Dec 01; 15(6):1574-87. PubMed ID: 25139763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.